Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PGC for GI Toxicity Mitigation During Pelvic Radiation
NCT07231588Phase 1Recruiting
- Sponsor
- University of Cincinnati
- Start
- Jan 2026
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Pendulum Glucose Control in Gastrointestinal injury, sponsored by University of Cincinnati. Primary endpoint: Probiotic Adherence Rate at 10 weeks. Started Jan 2026; status: recruiting.
02
Drugs
Pendulum Glucose Control
03
Conditions
Gastrointestinal injury
Beyond the preview
Go deeper on NCT07231588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07231588.